Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 616025, 9 pages
http://dx.doi.org/10.1155/2014/616025
Research Article

Estrogen-Related Receptor Alpha Confers Methotrexate Resistance via Attenuation of Reactive Oxygen Species Production and P53 Mediated Apoptosis in Osteosarcoma Cells

1First School of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510405, China
2Cancer Center, University of California, Davis, Sacramento, CA 95817, USA
3State Key Hip Joints Center, First Affiliated Hospital of Guangzhou University of Chinese Medicine, No. 12 Jichang Road, Guangzhou, Guangdong 510405, China

Received 26 March 2014; Accepted 25 April 2014; Published 19 May 2014

Academic Editor: Jianzhen Xu

Copyright © 2014 Peng Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Huang, J. Ni, K. Liu et al., “HMGB1 promotes drug resistance in osteosarcoma,” Cancer Research, vol. 72, no. 1, pp. 230–238, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Ma, Y. Ren, E. Q. Han et al., “Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy,” Biochemical and Biophysical Research Communications, vol. 431, no. 2, pp. 274–279, 2013. View at Publisher · View at Google Scholar
  3. K. Bienemann, M. S. Staege, S. J. Howe, M. Sena-Esteves, H. Hanenberg, and C. M. Kramm, “Targeted expression of human folylpolyglutamate synthase for selective enhancement of methotrexate chemotherapy in osteosarcoma cells,” Cancer Gene Therapy, vol. 20, no. 9, pp. 514–520, 2013. View at Publisher · View at Google Scholar
  4. W. Yang, X. Liu, E. Choy, H. Mankin, F. J. Hornicek, and Z. Duan, “Targeting hedgehog-GLI-2 pathway in osteosarcoma,” Journal of Orthopaedic Research, vol. 31, no. 3, pp. 502–509, 2013. View at Publisher · View at Google Scholar
  5. G. Bernatchez, V. Giroux, T. Lassalle, A. C. Carpentier, N. Rivard, and J. C. Carrier, “ERRα metabolic nuclear receptor controls growth of colon cancer cells,” Carcinogenesis, vol. 34, no. 10, pp. 2253–2261, 2013. View at Publisher · View at Google Scholar
  6. R. Sladek, J.-A. Bader, and V. Giguere, “The orphan nuclear receptor estrogen-related receptor alpha is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene,” Molecular and Cellular Biology, vol. 17, no. 9, pp. 5400–5409, 1997. View at Google Scholar
  7. T. Suzuki, Y. Miki, T. Moriya et al., “Estrogen-related receptor α in human breast carcinoma as a potent prognostic factor,” Cancer Research, vol. 64, no. 13, pp. 4670–4676, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Sun, J. Sehouli, C. Denkert et al., “Expression of estrogen receptor-related receptors, a subfamily of orphan nuclear receptors, as new tumor biomarkers in ovarian cancer cells,” Journal of Molecular Medicine, vol. 83, no. 6, pp. 457–467, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Fujimura, S. Takahashi, T. Urano et al., “Increased expression of estrogen-related receptor α (ERRα) is a negative prognostic predictor in human prostate cancer,” International Journal of Cancer, vol. 120, no. 11, pp. 2325–2330, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Cavallini, M. Notarnicola, R. Giannini et al., “Oestrogen receptor-related receptor alpha (ERRα) and oestrogen receptors (ERα and ERβ) exhibit different gene expression in human colorectal tumour progression,” European Journal of Cancer, vol. 41, no. 10, pp. 1487–1494, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Wu, J. Wang, Y. Wang, T.-T. Kwok, S.-K. Kong, and C. Wong, “Estrogen-related receptor α (ERRα) inverse agonist XCT-790 induces cell death in chemotherapeutic resistant cancer cells,” Chemico-Biological Interactions, vol. 181, no. 2, pp. 236–242, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Wang, Y. Wang, and C. Wong, “Oestrogen-related receptor alpha inverse agonist XCT-790 arrests A549 lung cancer cell population growth by inducing mitochondrial reactive oxygen species production,” Cell Proliferation, vol. 43, no. 2, pp. 103–113, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. T. P. Devasagayam, J. C. Tilak, K. K. Boloor, K. S. Sane, S. S. Ghaskadbi, and R. D. Lele, “Free radicals and antioxidants in human health: current status and future prospects,” The Journal of Association of Physicians of India, vol. 52, pp. 794–804, 2004. View at Google Scholar · View at Scopus
  14. C. R. Hunt, J. E. Sim, S. J. Sullivan et al., “Genomic instability and catalase gene amplification induced by chronic exposure to oxidative stress,” Cancer Research, vol. 58, no. 17, pp. 3986–3992, 1998. View at Google Scholar · View at Scopus
  15. E. M. Mills, K. Takeda, Z.-X. Yu et al., “Nerve growth factor treatment prevents the increase in superoxide produced by epidermal growth factor in PC12 cells,” The Journal of Biological Chemistry, vol. 273, no. 35, pp. 22165–22168, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Herman, N. Zurgil, and M. Deutsch, “Low dose methotrexate induces apoptosis with reactive oxygen species involvement in T lymphocytic cell lines to a greater extent than in monocytic lines,” Inflammation Research, vol. 54, no. 7, pp. 273–280, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. C.-C. Huang, P.-C. Hsu, Y.-C. Hung et al., “Ornithine decarboxylase prevents methotrexate-induced apoptosis by reducing intracellular reactive oxygen species production,” Apoptosis, vol. 10, no. 4, pp. 895–907, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Yi, P. M. Clark, D. E. Mason et al., “Phosphofructokinase 1 glycosylation regulates cell growth and metabolism,” Science, vol. 337, no. 6097, pp. 975–980, 2012. View at Publisher · View at Google Scholar
  19. M.-J. Lee, S.-H. Kao, J.-E. Hunag et al., “Shikonin time-dependently induced necrosis or apoptosis in gastric cancer cells via generation of reactive oxygen species,” Chemico-Biological Interactions, vol. 211, pp. 44–53, 2014. View at Publisher · View at Google Scholar
  20. G. Waris and H. Ahsan, “Reactive oxygen species: role in the development of cancer and various chronic conditions,” Journal of Carcinogenesis, vol. 5, article 14, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Boonstra and J. A. Post, “Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells,” Gene, vol. 337, pp. 1–13, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Li, L. He, N. Zeng et al., “Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) signaling regulates mitochondrial biogenesis and respiration via estrogen-related receptor α (ERRα),” The Journal of Biological Chemistry, vol. 288, no. 35, pp. 25007–25024, 2013. View at Publisher · View at Google Scholar
  23. E. Bonnelye and J. E. Aubin, “An energetic orphan in an endocrine tissue: a revised perspective of the function of estrogen receptor-related receptor alpha in bone and cartilage,” Journal of Bone and Mineral Research, vol. 28, no. 2, pp. 225–233, 2013. View at Publisher · View at Google Scholar
  24. P. M. Hwang, F. Bunz, J. Yu et al., “Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells,” Nature Medicine, vol. 7, no. 10, p. 1117, 2001. View at Google Scholar
  25. T. Yamaguchi, Y. Miki, and K. Yoshida, “Protein kinase C δ activates IκB-kinase α to induce the p53 tumor suppressor in response to oxidative stress,” Cellular Signalling, vol. 19, no. 10, pp. 2088–2097, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Bonnelye and J. E. Aubin, “Estrogen receptor-related receptor α: a mediator of estrogen response in bone,” The Journal of Clinical Endocrinology & Metabolism, vol. 90, no. 5, pp. 3115–3121, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. C. P. Cheung, S. Yu, K. B. Wong et al., “Expression and functional study of estrogen receptor-related receptors in human prostatic cells and tissues,” The Journal of Clinical Endocrinology & Metabolism, vol. 90, no. 3, pp. 1830–1844, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Bonnelye, N. Laurin, P. Jurdic, D. A. Hart, and J. E. Aubin, “Estrogen receptor-related receptor-α (ERR-α) is dysregulated in inflammatory arthritis,” Rheumatology, vol. 47, no. 12, pp. 1785–1791, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. I. Delhon, S. Gutzwiller, F. Morvan et al., “Absence of estrogen receptor-related-α increases osteoblastic differentiation and cancellous bone mineral density,” Endocrinology, vol. 150, no. 10, pp. 4463–4472, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. R. A. Zirngibl, J. S. M. Chan, and J. E. Aubin, “Estrogen receptor-related receptor α (ERRα) regulates osteopontin expression through a non-canonical ERRα response element in a cell context-dependent manner,” Journal of Molecular Endocrinology, vol. 40, no. 2, pp. 61–73, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Wang and J. Wang, “Estrogen-related receptor alpha interacts cooperatively with peroxisome proliferator-activated receptor-gamma coactivator-1alpha to regulate osteocalcin gene expression,” Cell Biology International, vol. 37, no. 11, pp. 1259–1265, 2013. View at Google Scholar
  32. W.-C. Huang, Z. Xie, H. Konaka, J. Sodek, H. E. Zhau, and L. W. K. Chung, “Human osteocalcin and bone sialoprotein mediating osteomimicry of prostate cancer cells: role of cAMP-dependent protein kinase A signaling pathway,” Cancer Research, vol. 65, no. 6, pp. 2303–2313, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Song, Q.-F. Cai, Y.-B. Mao, Y.-L. Ming, S.-D. Bao, and G.-L. Ouyang, “Osteopontin promotes ovarian cancer progression and cell survival and increases HIF-1α expression through the PI3-K/Akt pathway,” Cancer Science, vol. 99, no. 10, pp. 1901–1907, 2008. View at Publisher · View at Google Scholar · View at Scopus